Early postoperative growth hormone levels: High predictive value for long-term outcome after surgery for acromegaly

Journal of Internal Medicine

Volumn 247, Issue 6, 2000, Pages 640-650

  Valdemarsson, Stig ^a   Ljunggren, S ^a   Bramnert, M ^a   Norrhamn, O ^a   Nordstrom C H ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acromegaly; Growth hormone; IGF 1; Pituitary; Pituitary tumour; Transsphenoidal surgery

Indexed keywords

GROWTH HORMONE; PROTIRELIN; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE TEST; GROWTH HORMONE RELEASE; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0033938671     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00667.x     Document Type: Article

References (37)

1. 1 Ross DA, Wilson CB. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J Neurosurgery 1988; 68: 854-67.
2. 2 Laws ER, Carpenter SM, Scheithauer BW, Randall RV. Long-term results of transphenoidal surgery for the management of acromegaly. In: Robbins R, Melmed S, eds. Acromegaly: a Century of Scientific and Clinical Progress. New York: Plenum Press, 1987; 241-48.
3. 3 Fahlbusch R, Honegger J. Buchfelder M. Surgical management of acromegaly. Endocrinol Metab North Am 1992; 21: 679-92.
4. 4 Lissett CA, Peacey SR, Laing I, Tetlow L, Davis JR, Shalet SM. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clin Endocrinol (Oxf) 1998; 5: 653-57.
5. 5 Fahlbuch R, Honegger J, Schott W, Buchfelder M. Results of surgery in acromegaly. In: Wass JAH, ed. Treating Acromegaly. Bristol, UK Journal of Endocrinology Press 1994; 49-54.
6. 6 Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Quart J Med 1969; 39: 1-16.
7. 7 Nabarro JDN. Acromegaly. Clin Endocrinol 1987; 26: 481-512.
8. 8 Bengtsson BÅ, Eden S, Ernest I, Oden A, Sjögren B. Epidemiology and long term survival in acromegaly. Acta Med Scand 1988; 223: 327-35.
9. 9 Gridley G, Hrubec H, Page W, Arora S, Fraumeni JF. Acromegaly and gastrointestinal cancer. Cancer 1991; 68: 1673-77.
10. 10 Bates AS, Van't Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Quart J Med 1993; 86: 293-99.
11. 11 Alexander L, Appelton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 1980; 12: 71-79.
12. 12 Bates AS, Van't Hoff W, Jones JM, Clayton RN. Does treatment of acromegaly affect life expectancy? Metabolism 1995; 44: 1-5.
13. 13 Orme SM, McNally RJQ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 1998; 83: 2730-34.
14. 14 Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsfenoidal microsurgery for growth hormone secreting ptuitary adenomas: initial outcome and long-tern results. J Clin Endocrinol Metab 1998; 83: 3411-18.
15. 15 Swearingen B, Barker FG, Katznelson L et al. Long-term mortality and transsfenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998; 83: 3419-26.
16. 16 Tidall GT, Oyesiku NM, Watts NB, Clark RV, Christy JH, Adams DA. Transsphenoidal adenomectomy for growth hormone-secreting adenomas in acromegaly: outcome analysis and determinants of failure. J Neurosurgery 1993; 78: 205-15.
17. 17 Osman IA, James RA, Chatterjee S, Mathias D, Kendall-Taylor P. Factors determining the long term outcome of surgery for acromegaly. Quart J Med 1994; 87: 617-23.
18. 18 Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 1994; 41: 95-102.
19. 19 Melmed S, Jackson I, Kleinberg D, Klibanski A. Current guidelines for acromegaly. J Clin Endocrinol Metab 1998; 83: 2646-52.
20. 20 Bynke O, Karlberg B, Kågedal B. Early postoperative growth hormone levels predict the result of transsfenoidal tumor removal in acromegaly. Acta Endocrinol (Copenh) 1990; 122: 443-49.
21. 21 Freda PU, Wardlaw SL, Post KD. Long-term endocrinological follow-up in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurgery 1998; 89: 353-58.
22. 22 van den Berg G, van Dulken H, Frölich M, Meinders AE, Rolsfema F. Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery. Clin Endocrinol 1998; 49: 45-51.
23. 23 Wilson CB. A decade of pituitary microsurgery. J Neurosurgery 1982; 61: 814-33.
24. 24 Hulting AL, Werner S, Wersäll J. Normal growth hormone secretion is rare after microsurgical normalisation of growth hormone levels in acromegaly. Acta Med Scand 1982; 212: 401-405.
25. 25 Faglia G, Paracchi A, Ferrari C, Beck-Peccoz P. Evaluation of the results of transsphenoidal surgery in acromegly by assessment of the growth hormone response to thyrotropin-releasing hormone. Clin Endocrinol 1978; 8: 373-80.
26. 26 Roelfsema F, Van Dulken H, Frolich M. Long term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol 1985; 23: 555-65.
27. 27 Valdemarsson S, Bramnert M, Cronquist S, Hedner P, Nordström CH, Strömblad LG. Early post-operative basal serum GH level and the GH response to TRH in relation to the longterm outcome of surgical treatment for acromegaly. A report on 39 patients. J Intern Med 1990; 230: 49-54.
28. 28 Jakobsson KE, Petruson B, Elfverson J, Bengtsson BÅ. Results of the lateral rhinotomy approach in transsfenoidal microsurgery for growth-hormone secreting pituitary adenoma. Br J Neurosurg 1995; 9: 763-68.
29. 29 Lindholm J, Giwercman B, Giwercman A. Investigations of the criterion for assessing the outcome of treatment in acromegaly. Clin Endocrinol 1987; 27: 553-62.
30. 30 Melmed S. Acromegaly. N Eng J Med 1990; 322: 966-75.
31. 31 Losa M, Oeckler R, Schopohl J, Muller AO, Alba-Lopez J, Von Werder K. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing of somatomedin-C measurement in acromegaly. J Neurosurgery 1989; 70: 561-67.
32. 32 Lamberts SWJ, Uitterlinden P, Schuijff PC. Therapy of acromegaly with sandostatin: the predictive value of an acute test, the value of somatomedin-C measurements in dose adjustment and the definition of a biochemical cure. Clin Endocrinol 1988; 29: 411-20.
33. 33 Chen HS, Lin HD. Serum IGF-1 and IGFBP-3 levels for the assessment of disease activity of acromegaly. J Endocronol Invest 1999; 22: 98-103.
34. 34 Rosén T, Bengtsson BÅ. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-88.
35. 35 Bülow B, Hagmar L, Mikoczy Z, Nordström CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997; 46: 75-81.
36. 36 Bates AS, Bullivant B, Sheppard C, Stewart PM. Life expectancy following surgery for pituitary tumors. Clin Endocrinol 1999; 50: 315-19.
37. 37 Freda PU, Post KD, Powell JS, Wardlaw SL. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab 1998; 83: 3808-16.